Development of Central Nervous System Metastases as a First Site of Metastatic Disease in Breast Cancer Patients Treated in the Neoadjuvant Trials GeparQuinto and GeparSixto

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-019-1144-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Correction: Neoadjuvant Trials in ER+ Breast Cancer: A Tool for Acceleration of Drug Development and Discovery

Cancer Discovery
Oncology
2019English

Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2018English

Brain Metastases in Patients With Metastatic Breast Cancer : Prognosis According to Subtype

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2017English

Burden of Symptoms Associated With Development of Metastatic Bone Disease in Patients With Breast Cancer

Supportive Care in Cancer
Oncology
2016English

Development of CNS Metastases and Survival in Patients With Inflammatory Breast Cancer

Cancer
Cancer ResearchOncology
2018English

Immunoperoxidase Labelled Antibody Staining in Differential Diagnosis of Central Nervous System Haemangioblastomas and Central Nervous System Metastases of Renal Carcinomas.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1986English

Paraneoplastic Damage to the Central and Peripheral Nervous System in Breast Cancer: A Case Report

Siberian Journal of Oncology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy